Search Login Register

tasquinimod Summary

Description: a lead second generation quinoline-3-carboxamide anti-angiogenic agent for the treatment of prostate cancer; structure in first source

Also Known As: 4-hydroxy-5-methoxy-N,1-dimethyl-2-oxo-N-((4-trifluoromethyl)phenyl)-1,2-dihydroquinoline-3-carboxamide; ABR-215050

Networked: 27 relevant articles (4 outcomes, 15 trials/studies) for this Bio-Agent

Key Diseases for which tasquinimod is Relevant

  1. Prostatic Neoplasms (Prostate Cancer) : 4 outcomes 12 studies in 22 results
  2. Neoplasms (Cancer) : 2 outcomes 6 studies in 15 results
  3. Neoplasm Metastasis (Metastasis) : 2 studies in 5 results
  4. Vascular Tissue Neoplasms : 2 studies in 2 results
  5. Disease Progression : 1 study in 4 results
Show All >>

Drugs Related to tasquinimod

  1. quinoline-3-carboxamide
  2. taxane
  3. Cytochrome P-450 CYP3A
  4. Ketoconazole (Nizoral)
  5. Cytochromes
  6. docetaxel (Taxotere)
  7. ipilimumab
  8. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
  9. tasquinimod
  10. sipuleucel-T (APC8015)
Show All >>

Therapies Related to tasquinimod

  1. Heterologous Transplantation (Xenotransplantation)
  2. Drug Therapy (Chemotherapy)
  3. Castration
  4. Immunomodulation
  5. Immunotherapy
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.